HHS Assails Merck's 'Misunderstandings' Of Drug Pricing Law

By Theresa Schliep · September 12, 2023, 8:22 PM EDT

Merck & Co. Inc.'s suit challenging the Inflation Reduction Act's Medicare drug price-negotiation program is teeming with "misunderstandings" of the law, the U.S. Department of Health and Human Services told a...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

MERCK & CO., INC. v. BECERRA et al

Case Number

1:23-cv-01615

Court

District Of Columbia

Nature of Suit

Civil Rights: Other

Date Filed

June 06, 2023